These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 34395542)

  • 1. Bone Quality in CKD Patients: Current Concepts and Future Directions - Part I.
    Asadipooya K; Abdalbary M; Ahmad Y; Kakani E; Monier-Faugere MC; El-Husseini A
    Kidney Dis (Basel); 2021 Jul; 7(4):268-277. PubMed ID: 34395542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone Quality in Chronic Kidney Disease Patients: Current Concepts and Future Directions - Part II.
    Asadipooya K; Abdalbary M; Ahmad Y; Kakani E; Monier-Faugere MC; El-Husseini A
    Kidney Dis (Basel); 2021 Sep; 7(5):359-371. PubMed ID: 34604343
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of osteoporosis in patients with chronic kidney disease.
    Abdalbary M; Sobh M; Elnagar S; Elhadedy MA; Elshabrawy N; Abdelsalam M; Asadipooya K; Sabry A; Halawa A; El-Husseini A
    Osteoporos Int; 2022 Nov; 33(11):2259-2274. PubMed ID: 35748896
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of dual energy X-ray absorptiometry, the trabecular bone score and quantitative computed tomography in the evaluation of chronic kidney disease-mineral and bone disorders.
    Pocock N
    Nephrology (Carlton); 2017 Mar; 22 Suppl 2():19-21. PubMed ID: 28429557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of DXA Bone Mineral Densitometry in Ontario: An Evidence-Based Analysis.
    Medical Advisory Secretariat
    Ont Health Technol Assess Ser; 2006; 6(20):1-180. PubMed ID: 23074491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions versus placebo, no treatment or usual care for osteoporosis in people with chronic kidney disease stages 3-5D.
    Hara T; Hijikata Y; Matsubara Y; Watanabe N
    Cochrane Database Syst Rev; 2021 Jul; 7(7):CD013424. PubMed ID: 34231877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Fragility fracture in the Chronic Kidney Disease (CKD)].
    Fusaro M; Aghi A; Mereu MC; Giusti A
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Bone Mineral Density With Fractures Across the Spectrum of Chronic Kidney Disease: The Regina CKD-MBD Study.
    Prasad B; Ferguson T; Tangri N; Ng CY; Nickolas TL
    Can J Kidney Health Dis; 2019; 6():2054358119870539. PubMed ID: 31467681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and treatment of osteoporosis in patients with chronic kidney disease : Joint guidelines of the Austrian Society for Bone and Mineral Research (ÖGKM), the Austrian Society of Physical and Rehabilitation Medicine (ÖGPMR) and the Austrian Society of Nephrology (ÖGN)].
    Cejka D; Wakolbinger-Habel R; Zitt E; Fahrleitner-Pammer A; Amrein K; Dimai HP; Muschitz C
    Wien Med Wochenschr; 2023 Oct; 173(13-14):299-318. PubMed ID: 36542221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone biopsy: an ally in the management of fragility fractures in chronic kidney disease.
    Aguiar F; Meng C; Pereira L; Brito I; Frazão JM
    Acta Reumatol Port; 2018; 43(3):201-209. PubMed ID: 30414368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Use of Imaging Techniques in Chronic Kidney Disease-Mineral and Bone Disorders (CKD-MBD)-A Systematic Review.
    Pimentel A; Bover J; Elder G; Cohen-Solal M; Ureña-Torres PA
    Diagnostics (Basel); 2021 Apr; 11(5):. PubMed ID: 33925796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vertebral bone quality score predicts fragility fractures independently of bone mineral density.
    Ehresman J; Schilling A; Yang X; Pennington Z; Ahmed AK; Cottrill E; Lubelski D; Khan M; Moseley KF; Sciubba DM
    Spine J; 2021 Jan; 21(1):20-27. PubMed ID: 32474223
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bone microarchitecture and estimated failure load are deteriorated whether patients with chronic kidney disease have normal bone mineral density, osteopenia or osteoporosis.
    Ghasem-Zadeh A; Bui M; Seeman E; Boyd SK; Iuliano S; Jaipurwala R; Mount PF; Toussaint ND; Chiang C
    Bone; 2022 Jan; 154():116260. PubMed ID: 34801763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fracture risk assessment in patients with chronic kidney disease.
    Jamal SA; West SL; Miller PD
    Osteoporos Int; 2012 Apr; 23(4):1191-8. PubMed ID: 21901475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trabecular Bone Score in Assessing Bone Mineralization Status in Children with End- Stage Renal Disease: A Promising Tool.
    Salem N; Bakr A; Eid R
    Eur J Pediatr; 2023 Nov; 182(11):4957-4967. PubMed ID: 37610434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fragility fractures and osteoporosis in CKD: pathophysiology and diagnostic methods.
    Salam SN; Eastell R; Khwaja A
    Am J Kidney Dis; 2014 Jun; 63(6):1049-59. PubMed ID: 24631043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A structural approach to skeletal fragility in chronic kidney disease.
    Leonard MB
    Semin Nephrol; 2009 Mar; 29(2):133-43. PubMed ID: 19371804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating Osteoporosis in Chronic Kidney Disease: Both Bone Quantity and Quality Matter.
    Lloret MJ; Fusaro M; Jørgensen HS; Haarhaus M; Gifre L; Alfieri CM; Massó E; D'Marco L; Evenepoel P; Bover J
    J Clin Med; 2024 Feb; 13(4):. PubMed ID: 38398323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of bone quality in patients with diabetes mellitus.
    Jiang N; Xia W
    Osteoporos Int; 2018 Aug; 29(8):1721-1736. PubMed ID: 29736760
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.